- This event has passed.
September 17 @ September 17 - September 17
On September 17, 2019, Blirt had the opportunity to participate in the ‘Business in Genes’ Conference co-organized by the Warsaw Stock Exchange.
The aim of the conference was to bring the biotechnology industry closer to analysts and journalists dealing with financial issues as a relatively new and foreign investment market.
The meeting was to show the potential that biotechnology companies have and the challenges they face, as well as to indicate the main barriers to the development of this industry.
Participants of the meeting representing Polish biotechnology companies unanimously admitted that Biotechnology has and will have an ever greater, positive impact on our lives, and long-term policy, construction of laboratory infrastructure and investing in Polish intellectual capital is an increasingly important element significantly affecting the development of innovation in Poland.
What is the answer to the question posed at the end of the conference: “Does the biotechnology industry have a chance to become a favorite of investors?”
When we look at the achievements of our clients creating new, exciting products based on our enzymes, and perhaps changing the lives of millions of people in the future, we believe the aswer is YES.
The presence and activities of Blirt on the global market clearly shows that the development of biotechnology can be not only a distant dream, but also a near reality.
We look forward to the re-release of this inspirational conference.